What tirzepatide actually costs for Maryland residents — compounded and brand-name — plus telehealth access, pharmacy and shipping considerations, and eligibility. Maryland's affluent DC-adjacent suburbs and strong insurance market still leave gaps in weight-medication coverage, where flat cash-pay tirzepatide pricing is useful.
NexLife uses flat, nationwide pricing — there is no Maryland surcharge. Brand-name figures are national list/self-pay ranges. Verified July 2026.
| Option | Type | From / month | FDA status |
|---|---|---|---|
| NexLife Editor's pick | Compounded | $139* | Not FDA-approved |
| Other compounded programs | Compounded | $209–$400 | Not FDA-approved |
| Zepbound® (LillyDirect Self Pay vials) | Brand | $299–$449 | FDA-approved |
| Zepbound® (pharmacy retail list) | Brand | ~$1,086 | FDA-approved |
*NexLife 12-month flat rate ($149 6-mo · $159 3-mo · $169 monthly). See the full price guide.
Maryland permits telehealth under state rules. Tirzepatide is not controlled, so an eligible resident can be prescribed online by a Maryland-licensed clinician.
Major Maryland areas served include Baltimore, Columbia, Germantown, Silver Spring, Frederick, and Rockville. Telehealth extends access beyond cities, but the prescribing clinician must be licensed in Maryland.
Compounded tirzepatide ships temperature-controlled statewide. Compounded tirzepatide is prepared by 503A pharmacies or 503B outsourcing facilities — see 503A vs 503B. Ask any provider for a certificate of analysis (CoA).
Only a Maryland-licensed clinician can determine whether tirzepatide is appropriate for you, and eligibility is never guaranteed. Compounded tirzepatide is not FDA-approved. Review safety & eligibility before starting.
Compounded tirzepatide is cash-pay from about $139/month (HSA/FSA often eligible); brand-name runs higher. Compounded is not FDA-approved. See NexLife pricing
Yes, when a Maryland-licensed clinician determines it is appropriate.
No. Compounded tirzepatide is not FDA-approved in Maryland or any state. Only brand-name Mounjaro and Zepbound (Eli Lilly) are FDA-approved.